this result from latest J&J trial is reassuring for viral vector vaccines’ efficacy against severe disease with the SA variant (64% in SA vs ~70% elsewhere) https://t.co/BwwW1GZxsQ— … (@declamare) February 24, 2021
this result from latest J&J trial is reassuring for viral vector vaccines’ efficacy against severe disease with the SA variant (64% in SA vs ~70% elsewhere) https://t.co/BwwW1GZxsQ